Transcatheter embolization is a process of placing synthetic material or medication called embolic agent into blood vessels through a catheter to block blood flow toward a specific area of the body. Embolization is a highly effective way to prevent abnormal bleeding and is minimally invasive as compared to open surgery. Additionally, the technology is proving its efficiency in treatment while performing complex surgeries. The global transcatheter embolization and occlusion devices market was valued at US$ 2.7 Bn in 2017 and is anticipated to expand at a CAGR of 7.9% from 2018 to 2026. The embolization coils segment dominated the global market in 2017.
Rise in prevalence of chronic diseases, technological advancements, increase in patient awareness and health care expenditure, and surge in need of treatment of complex diseases drive the global market. The embolization particles segment is expected to expand at the highest CAGR during the forecast period. The segment has witnessed strong growth owing to increase in demand for drug-eluting particles and radioembolization particles. The highly fragmented nature of the global transcatheter embolization and occlusion devices market has prompted market players to shift focus toward relatively niche segments such as liquid embolics.
Request to View Sample of Report –
The global transcatheter embolization and occlusion devices market has been segmented based on product, application, end-user, and region. In terms of product, the global market has been classified into embolization coils, coiling-assist devices, embolization particles, flow diverter devices, liquid embolics, and accessories. The embolization coils segment has been bifurcated into pushable coils and detachable coils. The coiling-assist devices segment has been segregated into stent-assisted coiling and balloon-assisted coiling. The embolization particles segment has been categorized into radioembolization particles, microspheres, drug-eluting beads, and others. The accessories segment has been divided into catheters, guide wires, and others.
Based on application, the global transcatheter embolization and occlusion devices market has been classified into peripheral vascular disease, neurology, oncology, urology, and others. The peripheral vascular disease segment is projected to hold major share of the global market due to increase in incidence of targeted diseases across various regions, rise in prevalence of lifestyle diseases, and ongoing technological advancements. In terms of end-user, the global market has been divided into hospitals, ambulatory surgical centers, and clinics. Growth of the hospitals segment can be attributed to the increase in prevalence of various chronic diseases.
Request to View Brochure of Report –
In terms of region, North America dominated the global transcatheter embolization and occlusion devices market in 2017, owing to a highly developed health care sector, increase in awareness among health care providers about transcatheter embolization and occlusion devices, and continuous evolution of products. North America is also an attractive market in term of revenue. Rise in government initiatives & laws and increase in population drive the transcatheter embolization and occlusion devices market in the region. Technological advancements and increase in adoption of advanced transcatheter embolization and occlusion devices are expected to propel the transcatheter embolization and occlusion devices market in Asia Pacific, Latin America, and Middle East & Africa during the forecast period.
Key players operating in the global transcatheter embolization and occlusion devices market include BTG plc, Boston Scientific Corporation, Medtronic plc, Penumbra, Inc., Cook Medical, Edwards Lifesciences Corporation, Merit Medical Systems, Johnson & Johnson Services, Inc., Pfizer, Inc., Stryker Corporation, Terumo Corporation, Sirtex Medical Limited, and Abbott Laboratories.